MedMen stock is tanking during Tuesday trading after MedMen Enterprises (CSE:MMEN) (OTCQX:MMNFF) posted its fourth-quarter results, in which net loss more than doubled to $82.9 million USD.
Net Loss Takes the Gloss off GainsOverall, MedMen Enterprises actually made some strong gains in fiscal 2019, with Q4 revenue of $42 million USD representing a year-over-year increase of 104%. The full fiscal year figure was a record $130 million USD, a massive gain of 227% from fiscal 2018. However, MedMen stock is feeling the burden of a net loss of $82.9 million USD for the quarter and ...
Read The Full Article On PotStockNews.com
Get the latest marijuana stock news, cannabis on stock news on PotStockNews
All content provided by Pot Stock News is subject to our Terms Of Use and Disclaimer.